Norobiik @"The #GlobalPatent of the drug ends on Tuesday 18 July, but in a number of countries Johnson & Johnson continues to control the market with #SecondaryPatents – for which small modifications are made to a product to extend a patent.
J&J’s decision will allow the Stop #Tuberculosis Partnership coalition to procure and supply generic #bedaquiline to 44 low- and middle-income countries" #GenericDrugs
Cheaper TB drugs for millions after global deal on patent rights agreed